![Steven Burke](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 502 783 $ al 31/08/2026
Steven K.
Burke is currently Director at LeukoSight, Inc. and AbFero Pharmaceuticals, Inc. Since 2019, Dr. Burke has been Chief Medical, Research & Development Officer at Akebia Therapeutics, Inc. Formerly, Dr. Burke was Medical Director & VP-Clinical Research at GelTex Pharmaceuticals, Inc. from 1994 to 2001, Associate Director-Clinical Research at Glaxo, Inc., Senior VP-Medical and Regulatory Affairs at Genzyme Corp.
in 2011, Chief Medical Officer & Senior Vice President at Proteon Therapeutics, Inc. from 2006 to 2019, and Chief Medical Officer at Protara Therapeutics, Inc. Education includes a doctorate from Weill Cornell Medical College and undergraduate studies at Harvard College.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 31/03/2026 | 547.098 ( 0,2 % ) | 502 783 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 17/06/2019 |
LeukoSight, Inc.
 LeukoSight, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics to treat autoimmune and inflammatory diseases | Director/Miembro de la Junta | - |
AbFero Pharmaceuticals, Inc.
 AbFero Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oral iron chelators for the treatment of diseases of iron overload | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
| PROTARA THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 01/01/2019 |
GelTex Pharmaceuticals, Inc.
 GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops non-absorbed, polymer-based pharmaceuticals | Director Técnico/Científico/I+D | 01/01/2001 |
| PROTARA THERAPEUTICS, INC. | Director Técnico/Científico/I+D | - |
Glaxo, Inc. | Corporate Officer/Principal | - |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Director Técnico/Científico/I+D | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 10 |
|---|---|
GelTex Pharmaceuticals, Inc.
GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops non-absorbed, polymer-based pharmaceuticals | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Proteon Therapeutics, Inc.
 Proteon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops pharmaceuticals products for patients with renal and vascular disease | Health Technology |
Akebia Therapeutics, Inc.
 Akebia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for kidney diseases | Health Technology |
Glaxo, Inc. | |
LeukoSight, Inc.
LeukoSight, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics to treat autoimmune and inflammatory diseases | Health Technology |
Weill Cornell Medical College
 Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AbFero Pharmaceuticals, Inc.
AbFero Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oral iron chelators for the treatment of diseases of iron overload | Health Technology |
Protara Therapeutics, Inc.
 Protara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
